Literature DB >> 4758049

Metabolism of trimethoprim in man and measurement of a new metabolite: a new fluorescence assay.

C W Sigel, M E Grace, C A Nichol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4758049     DOI： 10.1093/infdis/128.supplement_3.s580

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  14 in total

1.  Trimethoprim-sulfamethoxazole in chronic bronchitis.

Authors:  G W Jordan; S F Krajden; P D Hoeprich; G A Wong; T H Peirce; D C Rausch
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

2.  Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates.

Authors:  Wangda Zhou; Kishore Viswanathan; Dennis Hill; Amy C Anderson; Dennis L Wright
Journal:  Drug Metab Dispos       Date:  2012-07-18       Impact factor: 3.922

Review 3.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 4.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

5.  Pharmacokinetics of sulfadiazine and trimethoprim in man.

Authors:  F Andreasen; L Elsborg; S Husted; O Thomsen
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

6.  Single dose pharmacokinetics of trimethoprim.

Authors:  G W Rylance; R H George; D E Healing; D G Roberts
Journal:  Arch Dis Child       Date:  1985-01       Impact factor: 3.791

7.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

8.  Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections.

Authors:  J Aarbakke; O Opshaug; A Digranes; A Høylandskjaer; G Fluge; H Fellner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 9.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

10.  Studies on the in vitro biological N-oxidation of trimethoprim.

Authors:  P J Watkins; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Oct-Dec       Impact factor: 2.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.